Literature DB >> 25879272

A review of platelet secretion assays for the diagnosis of inherited platelet secretion disorders.

Andrew D Mumford, Andrew L Frelinger, Christian Gachet, Paolo Gresele, Patrizia Noris, Paul Harrison, Diego Mezzano1.   

Abstract

Measurement of platelet granule release to detect inherited platelet secretion disorders (IPSDs) is essential for the evaluation of patients with abnormal bleeding and is necessary to distinguish which granule sub-types are affected and whether there is abnormal granule bio-synthesis or secretion. The radioactive serotonin incorporation and release assay, described before 1970, is still considered the "gold standard" test to assess platelet δ-granule release, although is unsuitable for clinical diagnostic laboratories. Luciferin-based assays, such as lumiaggregometry, are the most widely performed alternatives, although these methods do not distinguish defects in δ-granule biosynthesis from defects in secretion. Platelet α-granule release is commonly evaluated using flow cytometry by measuring surface exposure of P-selectin after platelet activation. However, this assay has poor sensitivity for some α-granule disorders. Only few studies have been published with more recently developed assays and no critical reviews on these methods are available. In this review, we describe the rationale for developing robust and accurate laboratory tests of platelet granule release and describe the characteristics of the currently available tests. We identify an unmet need for further systematic evaluation of new assays and for standardisation of methodologies for clinical diagnostic laboratories.

Entities:  

Keywords:  Platelet pathology; acquired; diagnosis management; exocytosis; inherited; secretion

Mesh:

Substances:

Year:  2015        PMID: 25879272     DOI: 10.1160/TH14-11-0999

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  18 in total

1.  Carbamylation of Integrin α IIb β 3: The Mechanistic Link to Platelet Dysfunction in ESKD.

Authors:  Veronika Binder; Barbara Chruścicka-Smaga; Brith Bergum; Stéphane Jaisson; Philippe Gillery; Joar Sivertsen; Tor Hervig; Marta Kaminska; Ronak Tilvawala; Venkatesh V Nemmara; Paul R Thompson; Jan Potempa; Hans-Peter Marti; Piotr Mydel
Journal:  J Am Soc Nephrol       Date:  2022-08-29       Impact factor: 14.978

Review 2.  Pulmonary Fibrosis in Hermansky-Pudlak Syndrome.

Authors:  Glenn W Vicary; Yeidyly Vergne; Alberto Santiago-Cornier; Lisa R Young; Jesse Roman
Journal:  Ann Am Thorac Soc       Date:  2016-10

3.  VE-1902-A direct thrombin inhibitor with reversible covalent mechanism of action shows efficacy with reduced bleeding in rodent models of thrombosis.

Authors:  Mohanram Sivaraja; Daniel M Clemens; Sivan Sizikov; Subhadra Dash; Chengpei Xu; Matthew Rienzo; Bo Yang; Molly Ryan; Madhuri Chattopadhyay; Lev Igoudin; Stephanie S Chang; Samuel Keutzer; Piotr Zalicki; M Angels Estiarte; Timothy P Shiau; Kevin M Short; David C Williams; Anirban Datta; Nicola Pozzi; Enrico Di Cera; C Michael Gibson; Keith A A Fox; David B Kita
Journal:  Thromb Res       Date:  2020-04-19       Impact factor: 3.944

Review 4.  Platelet-Rich Plasma Therapy in the Treatment of Diseases Associated with Orthopedic Injuries.

Authors:  Jie Fang; Xin Wang; Wen Jiang; Yaqiong Zhu; Yongqiang Hu; Yanxu Zhao; Xueli Song; Jinjuan Zhao; Wenlong Zhang; Jiang Peng; Yu Wang
Journal:  Tissue Eng Part B Rev       Date:  2020-11-03       Impact factor: 7.376

Review 5.  Optimisation of platelet concentrates therapy: Composition, localisation, and duration of action.

Authors:  Yuk-Lin Yung; Sai-Chuen Fu; Yau-Chuk Cheuk; Ling Qin; Michael Tim-Yun Ong; Kai-Ming Chan; Patrick Shu-Hang Yung
Journal:  Asia Pac J Sports Med Arthrosc Rehabil Technol       Date:  2017-01-30

Review 6.  Inherited platelet disorders: toward DNA-based diagnosis.

Authors:  Claire Lentaigne; Kathleen Freson; Michael A Laffan; Ernest Turro; Willem H Ouwehand
Journal:  Blood       Date:  2016-04-19       Impact factor: 25.476

7.  Inhibition of angiogenesis by platelets in systemic sclerosis patients.

Authors:  Daniela Hirigoyen; Paula I Burgos; Veronica Mezzano; Josefina Duran; Magaly Barrientos; Claudia G Saez; Olga Panes; Diego Mezzano; Mirentxu Iruretagoyena
Journal:  Arthritis Res Ther       Date:  2015-11-19       Impact factor: 5.156

8.  Dynamic monitoring of platelet activation and its role in post-dissection inflammation in a canine model of acute type A aortic dissection.

Authors:  Chaoyi Qin; Hongwei Zhang; Jun Gu; Zhenghua Xiao; Qin Yang; Wei Meng
Journal:  J Cardiothorac Surg       Date:  2016-05-26       Impact factor: 1.637

9.  Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders.

Authors:  Veronique Latger-Cannard; Christophe Philippe; Alexandre Bouquet; Veronique Baccini; Marie-Christine Alessi; Annick Ankri; Anne Bauters; Sophie Bayart; Pascale Cornillet-Lefebvre; Sylvie Daliphard; Marie-Joelle Mozziconacci; Aline Renneville; Paola Ballerini; Guy Leverger; Hagay Sobol; Philippe Jonveaux; Claude Preudhomme; Paquita Nurden; Thomas Lecompte; Remi Favier
Journal:  Orphanet J Rare Dis       Date:  2016-04-26       Impact factor: 4.123

10.  RGS10 Negatively Regulates Platelet Activation and Thrombogenesis.

Authors:  Nicole R Hensch; Zubair A Karim; Kirk M Druey; Malú G Tansey; Fadi T Khasawneh
Journal:  PLoS One       Date:  2016-11-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.